Stay updated on Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.

Latest updates to the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA minor platform/version update for the ClinicalTrials.gov site display (Revision v3.5.3 vs v3.5.2) is reflected on the page, without changing the underlying “record history” study details.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Record History shows a new revision labeled v3.4.3, replacing the previous v3.4.2. This indicates a minor site update.SummaryDifference0.1%

- Check73 days agoChange DetectedA new version entry was added to the record history on 2023-01-10. It documents updates to recruitment status, study status, and related study details (design, contacts/locations).SummaryDifference0.1%

- Check87 days agoChange DetectedThe record history now shows a new revision entry (v3.4.2) and the previous revision (v3.4.1) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Gaucher Disease Type 1 or 3 Clinical Trial page.